NanoDiagnotic Technology I-Corps Training

项目摘要 暴露于有机磷（OP）农药，可导致急性或慢性中毒， 这是世界范围内的主要环境和职业健康问题。有必要 一个简单，快速，具有成本效益，准确的生物监测工具，用于筛选/评估个人 暴露于OP农药。为了解决这些问题，纳米诊断技术有限责任公司（NDT） 建议开发一个集成的智能手机/纳米传感器平台，作为新的 生物监测工具，用于现场、快速和准确地检测个人暴露于OP 仅需最少的手指采血就能检测出杀虫剂，并获得了NIEHS STTR奖。 第一阶段资助，期限为2021年6月1日至2022年5月31日。从项目开始，我们 在技术开发上下了很大的功夫，取得了很大的进步，取得了很大的成绩。 有希望的结果。与此同时，我们积极研究如何将 技术.我们需要了解市场的需求和客户的需求 技术。2021年9月，公司组建团队，参加了2021年第四届中国国际汽车工业展览会。 为期六周的NSF I-Corps 2021年秋季培训计划在夏洛特夏洛特Ventureprise举行， 通过访谈进行客户发现。我们还需要更多关于 我们的技术商业化。我们非常高兴能有这个机会， NIH I-Corps培训计划，并渴望参加该培训计划并获得 更多地了解如何将我们的技术从实验室转化为市场， 更多的信息，包括但不限于，进一步发现客户，市场需求， 战略合作伙伴、竞争对手、投资者、在该领域建立网络等完成后 培训计划，我们将能够建立我们的整体商业化战略，并编写一个 强有力的建议，包括STTR第二阶段的技术和商业化计划 应用程序.

Project Summary Exposure to organophosphate (OP) pesticides, which can cause acute or chronic poisoning, is the major environmental and occupational health problem across the world. There is a need for a simple, rapid, cost-effective, and accurate biomonitoring tool for screening/assessing personal exposure to OP pesticides. To address these issuers, NanoDiagnostic Technology, LLC (NDT) proposed to develop an integrated smartphone/nanosensor platform serving as a new biomonitoring tool for onsite, rapid, and accurate detection of personal exposure to OP pesticides just using a minimal finger-prick blood sample and won an award of NIEHS STTR phase I grant with the duration of June 1 2021 to May 31, 2022. Since starting the project, we put great efforts on the technology development and made great progress and obtained very promising results. At the same time, we actively worked on how to commercialize the technology. We need to understand the needs of the market and where the customers are for the technology. In September , 2021, the company formed a team and participated in a six-week NSF I-Corps Fall 2021 training program at the UNC Charlotte Ventureprise and conducted customer discovery through interviews. We still need more information on the commercialization of our technology. We are very excited about this opportunity offered by the NIH I-Corps Training program and eager to participate in this training program and acquire more knowledge on how to translate our technology from a lab to the marketplace and gain more information including but not limited to, further discovering customers, the need of market, strategic partners, competitors, investors, building network in the field, etc. After completing this training program, we will be able to establish our overall commercialization strategy and write a strong proposal including both the technology and commercialization plan for STTR phase II application.